Lawyers for Ovarian Cancer Victims Call on Regulators to Stop 'Contemptible' Johnson & Johnson Bankruptcy Plan

 
 

Attorneys representing several thousand women diagnosed with ovarian cancer after exposure to Johnson & Johnson (NYSE: JNJ) Baby Powder and other talc-based products are denouncing the company over reports it is considering bankruptcy to avoid financial responsibility.

 

"This is about as contemptible as it gets," says attorney Leigh O'Dell of Beasley Allen , co-lead counsel of the plaintiff's steering committee in federal multidistrict litigation (MDL) in New Jersey . "These women have suffered enough. If this report is true, we believe it's time for Congress and the Securities and Exchange Commission to investigate and outlaw cash-rich companies from playing corporate shell games and using federal bankruptcy law to avoid paying the victims they've hurt and misled."

 

According to a July 28 report by the Reuters news agency, " Exclusive: J&J exploring putting talc liabilities into bankruptcy - sources," the company, which enjoys a $443 billion market capitalization, is considering bankruptcy to limit financial exposure to thousands of lawsuits related to its talc-based products, including Johnson's Baby Powder and Shower to Shower brands.

 

Dozens of studies published in peer-reviewed journals during the past 25 years have shown a statistically significant association between talc use and ovarian cancer. Documents produced at trial show that the company was aware of the possible dangers as far back as the 1960s.

 

Since 2013, juries in numerous trials have found J&J liable for compensatory and punitive damages to ovarian cancer victims, although many verdicts were later overturned in appellate courts on jurisdictional grounds, but not on the merits of the case.

 

Last year, a Missouri appellate court entered a $2.1 billion judgment against the company. Justices found "significant reprehensibility" in J&J's handling of the issue of asbestos in its baby powder and concluded that J&J avoided "adopting more accurate measures for detecting asbestos," while discussing the asbestos risk of the powder in internal memos and refusing until recently to replace talc in its baby powder with corn starch, which doesn't pose a cancer risk.

 

Both the Missouri Supreme Court and the United States Supreme Court declined to overturn the award. A bankruptcy filing could significantly reduce the compensation available to remaining claimants and would prevent them from having their day in court.

 

"Solvent corporations should not be able to abuse the bankruptcy process to shield themselves from their responsibilities," says trial lawyer Michelle Parfitt , co-lead counsel in the federal talc MDL and a senior partner in the law firm, Ashcraft & Gerel. "This would be corporate welfare of the worst kind. And who would suffer the most? The women who have already lost so much due to J&J's behavior. I believe they are attempting to intimidate them by threatening bankruptcy. It won't work."

 

  About the Beasley Allen Law Firm  
Headquartered in Montgomery, Ala. , Beasley Allen is comprised of more than 70 attorneys and 200 support staff. One of the largest Plaintiffs law firms in the country, Beasley Allen is a national leader in civil litigation, with verdicts and settlements in excess of $26 billion . For more information visit www.beasleyallen.com .

 

Contact:

 

  Mike Androvett  
Androvett Legal Media
800-559-4534

 

 Cision View original content: https://www.prnewswire.com/news-releases/lawyers-for-ovarian-cancer-victims-call-on-regulators-to-stop-contemptible-johnson--johnson-bankruptcy-plan-301336142.html  

 

SOURCE Beasley Allen Law Firm

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×